At David Nebbeling DO - Advanced Osteopathic Health, PLC, we use advanced science and FDA-approved procedures to deliver sustainable solutions to low testosterone, weight loss, and skin care. Our clinician-managed sites work around your schedule and your time.
Chronic pain is one of the common conditions we treat, that you need to fight with uncommon solutions. According to a recent Gallup-Healthways study, close to one half of adults report they suffer from some type of chronic ongoing pain.
"Playing with pain" is both a bad idea and often unnecessary. According to a recent Safe Kids Worldwide survey, 1.35 million children have a sports-related injury severe enough to send them to an emergency room each year.
The downside risks for being overweight may be worse than you think. According to the Centers for Disease Control and Prevention, 36 percent of American adults are obes,. and with obesity, there are related health risks.
When you're tired of being tired, you need to try alternative treatments. Chronic fatigue syndrome (CFS) is a major public health problem. Estimates indicate as many as 800,000 adults in the U.S. have CFS. Yet fewer than 20% of these seek help.
Bio-identical is one of the best options for both men and women who suffer from hormonal imbalances as they age. On this page are common symptoms associated with menopause (women) and andropause (men).
When you're fighting arthritis, you need to consider every available option. At Advanced Osteopathic Health in Lansing, we are practitioners of an important and often overlooked treatment option for rheumatic and related diseases, known as Dr. Brown's protocol.
When you're facing a killer, you need to use every weapon that's available. Heart disease, also known as coronary artery disease, or coronary heart disease, is the number one cause of death in the U.S., affecting more than 13 million Americans.
If you've been told nothing else can be done, it's time to take another look. Macular degeneration, also know as age-related macular degeneration (AMD), is the leading cause of permanent impairment of reading and fine or close-up vision among people aged 65 years and older.